Tag | Content |
---|
EnhancerAtlas ID | HS073-00507 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr1:44297270-44299290 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXP1 | MA0481.2 | chr1:44297513-44297525 | GTGTAAACAGAA | + | 6.22 | SREBF1 | MA0595.1 | chr1:44298876-44298886 | ATCACCCCAC | + | 6.02 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_33917 | chr1:44296122-44303313 | HCC1954 | SE_43787 | chr1:44295752-44303700 | MM1S | SE_61734 | chr1:44294901-44320400 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I043830 | chr1 | 44296621 | 44302937 |
|
Enhancer Sequence | TGGCTTTTTG GAAACTGTTT TGTGGAAACA GTGATCTTCT CCCTTCATTT CTCCAGTACC 60 ATTCAGCTCA TGCTGGATAC ATCATTTCAT GAGGCTGCGC TATCCTTCCT GAGACCTGGG 120 AGTATCTCAA AGATGGGACT GCTTTGTTGG TCATGAACAC ACACCAGTGT CAGAGAGTGC 180 AGGGAAAGTG TAAATGGTAA TTTGTTTTCT GGTCATATTA AATGTATCAT TTGACATTTT 240 ATAGTGTAAA CAGAACAGTG CATCTTCTAA CCATGGCTTC TCCTGGACTC CTTCAGCCCC 300 ATATGCCTGG GTCTAAGGGA GGTACTACTT TGTAGAGGAT TGTTGTAAAG CTGAATTAGA 360 TCATTAGATC CGCTGTCTGG TGCCTGGTTT GTGCTCAGTG AATGTTACTT CTCTTGTGTC 420 TTTCACTACC ACCCAGAAAG AGGATGTGTT TTTATTTTTA AGGAAATAAA GTGTGGAAGC 480 AAAATTGAAT TGGAGAGTCA CAGCAGATCT CTGGTGGAGT GCCTCCGTGA AAATTGTCTG 540 TTGAAGCACT TGGAGAACTT AGTGGGGAGC ATCCCTCCAG CTAAGAGGAA ATAAATTACA 600 AGGCTCTGGA GACAAATGTA ACCTGGAGTT AATGTCAGCT CCACAATCAC TGATCAAATA 660 GGAAGGTGGC CTGGTTTGAT GAAAAGGTAT TGCAGTGCCT AGCAGCAAGA GCAGAAAGGC 720 AGGGCCTCCG GAGCTGAGAA ATACCACAAG TTTCAGATGG CTCAGATCAA GCAGTCCCTT 780 TTTTCTTAAA GTGATAGAAG ACATTTGACA GTGCTTCAGC ATTTGTCGTA GATGGCTGTA 840 CACGTATCAT GATGGCAAAA GCTGTAGAGA AACCTGAGTC TACATTGGAA GCCACAAAGA 900 GCAAAGAGTC AGTGATGTCT AGGGTAGAAT GGATTGGCAC AGCCCACATG TGGGTAGATG 960 ATGAAACTGG TGACAATGCA AGCAAGACCC AGCAGACCTT GGAGTAACAG GTCAGACAGG 1020 TGGCAGTCAG AGGAGACAGA AGTTGTCCTT AAGGAGAAAC ATTTCCATCT TGGGGCTTGA 1080 GAGGATCTAT GGCAGTAAAG GCTATTTCAA AAAAAAAATT AAAGTGAAAA TATTTAATGA 1140 CAGAATAGGA TTACTCAAGC TAGGCGAAGC TGCTTCTGCC ATTTCCCTCC TCATGTCATT 1200 ATCCCAGAAA CAACTCTCTA GTACTTGGAG AAAGGCATCC TCATGAGGAA GGTAGAAGAT 1260 GGAATTGAAG AATTCCCTCC TCTGTGGATG GAAAGAGCTC TGTGTAGAGA GGCTCATCTG 1320 CACGCTCATG CATGTCCCCC TAGCATGGTA ACACTGGCTT TGATTAAGCT GCTGGGTTGT 1380 TAGGCAGTGT GCTAAGTGCT GCCTACATGG TCTTCTTTTC TCATAAGGAA TGCTTTAAAC 1440 TAAATTAGCA CATGAAACGA GGGAGCAGGC ATGGTAGGGG CTGATCTGAG TCCAGTCCTC 1500 TCTGAGATGG TTCTAGAAAC TAGACTGATG GTTACACAAT GTCCATCACT GATCTGTAGA 1560 GTCCTCAGGA ATCACTGTCA ATGACTCTTC CCCAGTTTCC CTGGCCATCA CCCCACTTCC 1620 CCCTTACACT TCCTGTTGAT TAACCTTCCA AGGCAAGGTA ACCAACTGAT TTCAGTCCAG 1680 CATTTTATTG GGTACTTGTA TATTCTGTGC CATACATGCT TTGCTAAAAT GATCATATTC 1740 TATGAGAGAA AGATATTTAA ATGGACAATT ACTCTTCAGT GTAATGGAGT GTAATGCTAG 1800 GCCTTAACTA TGTCCTAGTC ATCATTGTAT CCTTAATCCC AGGCCAGTTA GTTAGCATGT 1860 ACTGAGCACC AGCGAGGGGC CAGACACCGT ACTCAGTGCC AGCCCTTCTT TCTCAGCATA 1920 ACTCTTAACA AAAAAATTTT ATAAAGTAAG TACTAGTATA ATCCCACTTT TAAAGATGTG 1980 CAAATTAAGG GCACAAAACA ATTTAAAAGA CATGCCCCAA 2020
|